Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and I Ob in normal human endometrium and endometrial carcinoma
1997

Wnt Gene Expression in Endometrial Cancer

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): TD Buil, L Zhang, MCP Rees, R Bicknell, AL Harris

Primary Institution: Imperial Cancer Research Fund, University of Oxford

Hypothesis

The study aims to evaluate the expression of seven Wnt genes in normal human endometrium and endometrial carcinoma to assess hormonal regulation and differential expression.

Conclusion

The study found that Wnt4 down-regulation, along with Wnt2, 3, and 5a, may be associated with endometrial carcinoma.

Supporting Evidence

  • Wnt2, 3, 4, and 5a mRNAs were expressed at higher levels in normal endometrial cells than in endometrial carcinoma cell lines.
  • Wnt4 mRNA expression was significantly higher in normal endometrium than in endometrial carcinoma.
  • Six out of seven Wnt genes were expressed endogenously in the human endometrium.

Takeaway

The study looked at how certain genes, called Wnt genes, behave in normal and cancerous endometrial tissues, finding that some genes are less active in cancer.

Methodology

The expression of Wnt genes was investigated using ribonuclease protection analysis on normal endometrial cells and endometrial carcinoma cell lines.

Limitations

The study had a limited number of normal endometrial samples for comparison.

Statistical Information

P-Value

0.03

Statistical Significance

p=0.03

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication